Author Archives: Marie Powers

A little irony here? FDA’s technical difficulties on social media webinar send folks a’Twitter’

For more than five years, the FDA was criticized for failing to provide clear guidance on how drug developers could use social media without running afoul of its marketing restrictions. Last month, the agency finally came through with two crucial…

Share

Pigoons, politicians and the periodic table: BioWorld’s 8th annual biotech summer reading list

Ah, the summer holidays. Time to unplug – for minutes, hours or days at a time – prop up your feet and kick back. But what about a good read? Should you grab a relaxing snoozer that won’t tax your…

Share

U.S., EU biotechs shouldn’t dally on oft-cited ‘China strategy’

SUZHOU, China – Global intellectual property lawyers and consultants are quick to advise U.S. and European biotechs that they need a “China strategy” – guidance that usually generates a response akin to Scarlett O’Hara’s famous “I’ll think about it tomorrow”…

Share

Happy Holidays! BioWorld’s 7th Annual Biotech Gift Guide

Who needs Black Friday and Cyber Monday, anyway? True biotech aficionados know they can find the perfect gift for everyone on their holiday list in BioWorld’s 7th Annual Biotech Holiday Gift Guide. Shoppers, start your engines. Personal Health Last year,…

Share

Patient Experience Still Undervalued in Regulating Drugs

As I write this, I’m sitting in the University of British Columbia/Vancouver General Hospital (UBC/VGH) Eye Care Centre, where my husband, Chuck, is completing post-tests at the conclusion of a six-month study on prosopagnosia, otherwise known as face blindness. The…

Share

History, Mystery, Gastronomy in the Mix in BioWorld’s 7th Annual Biotech Summer Reading List

With the official start of summer just around the corner, BioWorld again polled industry execs and our own indefatigable staff to construct a diverse list of titles for your reading pleasure. Whether the summer solstice takes you to a deck…

Share

Statistical Tinkering in Device Regulation a Disservice to Patients

Despite the regulatory approval of new antiepileptic drugs (AED) over the past decade and the expansion of indications deemed suitable for epilepsy surgery, individuals with intractable seizures – roughly one in three epilepsy patients – still face a dearth of…

Share

BioWorld’s 6th Annual Holiday Gift Guide

It’s that time of year, when some thoughts turn to sugar plum fairies and others to the J.P. Morgan Healthcare Conference – or JPM#13 as it’s now widely known. Before you pop the cork on another New Year, however, it’s…

Share

BioWorld’s Biotech Summer Reading List Plumbs the Classics, BioEthics & Life’s Simple Pleasures

With the 2012 BIO International Convention behind us and the Fourth of July signaling summer vacation season in earnest, thoughts turn to visions of sun, sand and afternoons lounging in a deck chair. Again this year, BioWorld polled biotech execs,…

Share

Find Your Lucky Number at BIO 2012

BOSTON – The 2012 BIO International Convention may have fallen a tad short of its nadir in 2007, when BIO attendance topped more than 20,000 people from 49 U.S. states, Washington D.C., Puerto Rico and more than 60 countries. But…

Share